Trials / Unknown
UnknownNCT02002988
Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation
Endomyocardial Botulinum Toxin Injection Can Prevent Drug-Resistant Paroxysmal Atrial Fibrillation: Pilot Study
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective non-randomized study was to assess the efficacy and safety of endomyocardial botulinum toxin injection in projections of main ganglionated plexuses of left atrium for preventing drug-resistant paroxysmal atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | endomyocardial BT injection |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-01-01
- Completion
- 2016-06-01
- First posted
- 2013-12-06
- Last updated
- 2015-09-23
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02002988. Inclusion in this directory is not an endorsement.